Investors

• Financials
  • Key Ratios
  • Financial Reports
  • Profit share proposal
  • Regarding repayment of capital
• Stock Exchange Releases
  • Order releases to your email
• Annual Report
• Strategy and Objectives
  • Vision & Mission
  • Objectives
  • Short Term Risks
  • Outlook for The Year
• Operating Environment
  • Diagnostics
• Share Information
  • Share Capital
  • Redemption Rights
  • Share Monitor
  • Share History
• Shareholders
  • Number Dispersion
  • Major Shareholders
  • Notifications on major holdings
  • Insider Register
  • Insider Regulations
• Corporate Governance
  • General Meeting
  • Articles of Association
  • Board of Directors
  • Board Meetings
  • President and CEO
  • Other Management
  • Remuneration
  • Internal Control and Risk Management
  • Auditors
  • Insider Regulations
  • Disclosure Policy
• Group Management
  • President and CEO
  • Board of Directors
  • Subsidiary Management
  • Management
  • Remuneration
• Shareholder Meetings
  • Proposal of the Board 11.4.2012
  • Minutes of the Annual General Meeting
• Fact sheet for investors

Corporate Governance

Biohit Oyj is a Finnish public limited company whose Series B share is quoted on NASDAQ OMX Helsinki in the Small cap/Healthcare group. The Biohit Group (hereafter abbreviated as ‘Biohit’) comprises the parent company Biohit Oyj and its foreign subsidiary, which primarily focus on sales and marketing for Biohit Oyj’s products. Biohit is headquartered in Helsinki.

Biohit’s administration complies with current legislation, standards and recommendations concerning public listed companies, the regulations of NASDAQ OMX Helsinki Oy, and Biohit Oyj’s Articles of Association. Biohit Oyj also follows the Finnish Corporate Governance Code for listed companies that was approved by the Securities Market Association in October 2008 and came into force on 1 January 2009. The Corporate Governance Code is available from www.cgfinland.fi .

Biohit Oyj Corporate Governance Statement 2011